Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

Older adults with diabetes using GLP-1 receptor agonist medications may face increased risk of serious eye conditions, study ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...

Uncover the truth about GLP-1 weight loss drugs like Ozempic and Mounjaro. Learn how they work, who benefits most, potential risks, and why experts say they can be game-changing tools for fighting ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health issues.

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...